勃起不全用薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Erectile Dysfunction Medicine Market Insights, Forecast to 2028

• レポートコード：QY2207C3822 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の勃起不全用薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に勃起不全用薬の世界市場のxxx％を占める「バイアグラ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「オンライン薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の勃起不全用薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの勃起不全用薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの勃起不全用薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 勃起不全用薬のグローバル主要メーカーには、Pfizer, Inc.、Dong-A ST Co., Ltd.、Eli Lilly and Company、Bayer AG、Vivus, Inc.、Teva Pharmaceutical Industries Ltd.、SK Chemicals、Meda Pharmaceuticals, Inc.、Cristalia Produtos Quimicos Farmaceuticos Ltda、Apricus Biosciences, Inc.、Futura Medical plc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 勃起不全用薬市場は、種類と用途によって区分されます。世界の勃起不全用薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 バイアグラ、シアリス、レビトラ、ステンドラ 【用途別セグメント】 オンライン薬局、小売薬局、病院 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 勃起不全用薬製品概要 - 種類別市場（バイアグラ、シアリス、レビトラ、ステンドラ） - 用途別市場（オンライン薬局、小売薬局、病院） - 調査の目的 ・エグゼクティブサマリー - 世界の勃起不全用薬販売量予測2017-2028 - 世界の勃起不全用薬売上予測2017-2028 - 勃起不全用薬の地域別販売量 - 勃起不全用薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別勃起不全用薬販売量 - 主要メーカー別勃起不全用薬売上 - 主要メーカー別勃起不全用薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（バイアグラ、シアリス、レビトラ、ステンドラ） - 勃起不全用薬の種類別販売量 - 勃起不全用薬の種類別売上 - 勃起不全用薬の種類別価格 ・用途別市場規模（オンライン薬局、小売薬局、病院） - 勃起不全用薬の用途別販売量 - 勃起不全用薬の用途別売上 - 勃起不全用薬の用途別価格 ・北米市場 - 北米の勃起不全用薬市場規模（種類別、用途別） - 主要国別の勃起不全用薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの勃起不全用薬市場規模（種類別、用途別） - 主要国別の勃起不全用薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の勃起不全用薬市場規模（種類別、用途別） - 主要国別の勃起不全用薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の勃起不全用薬市場規模（種類別、用途別） - 主要国別の勃起不全用薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの勃起不全用薬市場規模（種類別、用途別） - 主要国別の勃起不全用薬市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer, Inc.、Dong-A ST Co., Ltd.、Eli Lilly and Company、Bayer AG、Vivus, Inc.、Teva Pharmaceutical Industries Ltd.、SK Chemicals、Meda Pharmaceuticals, Inc.、Cristalia Produtos Quimicos Farmaceuticos Ltda、Apricus Biosciences, Inc.、Futura Medical plc. ・産業チェーン及び販売チャネル分析 - 勃起不全用薬の産業チェーン分析 - 勃起不全用薬の原材料 - 勃起不全用薬の生産プロセス - 勃起不全用薬の販売及びマーケティング - 勃起不全用薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 勃起不全用薬の産業動向 - 勃起不全用薬のマーケットドライバー - 勃起不全用薬の課題 - 勃起不全用薬の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Erectile Dysfunction Medicine Market
Due to the COVID-19 pandemic, the global Erectile Dysfunction Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Viagra accounting for % of the Erectile Dysfunction Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Online Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Erectile Dysfunction Medicine market size is valued at US$ million in 2021, while the US and Europe Erectile Dysfunction Medicine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Erectile Dysfunction Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Erectile Dysfunction Medicine include Pfizer, Inc., Dong-A ST Co., Ltd., Eli Lilly and Company, Bayer AG, Vivus, Inc., Teva Pharmaceutical Industries Ltd., SK Chemicals, Meda Pharmaceuticals, Inc. and Cristalia Produtos Quimicos Farmaceuticos Ltda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Erectile Dysfunction Medicine Scope and Segment
Erectile Dysfunction Medicine market is segmented by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Erectile Dysfunction Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2017-2028.
Segment by Type
Viagra
Cialis
Levitra
Stendra
Segment by Distribution Channel
Online Pharmacies
Retail Pharmacies
Hospital
By Company
Pfizer, Inc.
Dong-A ST Co., Ltd.
Eli Lilly and Company
Bayer AG
Vivus, Inc.
Teva Pharmaceutical Industries Ltd.
SK Chemicals
Meda Pharmaceuticals, Inc.
Cristalia Produtos Quimicos Farmaceuticos Ltda
Apricus Biosciences, Inc.
Futura Medical plc.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Erectile Dysfunction Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Viagra
1.2.3 Cialis
1.2.4 Levitra
1.2.5 Stendra
1.3 Market by Distribution Channel
1.3.1 Global Erectile Dysfunction Medicine Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Erectile Dysfunction Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Erectile Dysfunction Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Erectile Dysfunction Medicine Sales by Region
2.4.1 Global Erectile Dysfunction Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Erectile Dysfunction Medicine by Region (2023-2028)
2.5 Global Erectile Dysfunction Medicine Revenue by Region
2.5.1 Global Erectile Dysfunction Medicine Revenue by Region (2017-2022)
2.5.2 Global Erectile Dysfunction Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Erectile Dysfunction Medicine Sales by Manufacturers
3.1.1 Global Top Erectile Dysfunction Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Erectile Dysfunction Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erectile Dysfunction Medicine in 2021
3.2 Global Erectile Dysfunction Medicine Revenue by Manufacturers
3.2.1 Global Erectile Dysfunction Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Erectile Dysfunction Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Medicine Revenue in 2021
3.3 Global Erectile Dysfunction Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Erectile Dysfunction Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Erectile Dysfunction Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Erectile Dysfunction Medicine Sales by Type
4.1.1 Global Erectile Dysfunction Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Erectile Dysfunction Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
4.2 Global Erectile Dysfunction Medicine Revenue by Type
4.2.1 Global Erectile Dysfunction Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Erectile Dysfunction Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Erectile Dysfunction Medicine Price by Type
4.3.1 Global Erectile Dysfunction Medicine Price by Type (2017-2022)
4.3.2 Global Erectile Dysfunction Medicine Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global Erectile Dysfunction Medicine Sales by Distribution Channel
5.1.1 Global Erectile Dysfunction Medicine Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global Erectile Dysfunction Medicine Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
5.2 Global Erectile Dysfunction Medicine Revenue by Distribution Channel
5.2.1 Global Erectile Dysfunction Medicine Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global Erectile Dysfunction Medicine Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global Erectile Dysfunction Medicine Price by Distribution Channel
5.3.1 Global Erectile Dysfunction Medicine Price by Distribution Channel (2017-2022)
5.3.2 Global Erectile Dysfunction Medicine Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America Erectile Dysfunction Medicine Market Size by Type
6.1.1 North America Erectile Dysfunction Medicine Sales by Type (2017-2028)
6.1.2 North America Erectile Dysfunction Medicine Revenue by Type (2017-2028)
6.2 North America Erectile Dysfunction Medicine Market Size by Distribution Channel
6.2.1 North America Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2028)
6.2.2 North America Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2028)
6.3 North America Erectile Dysfunction Medicine Market Size by Country
6.3.1 North America Erectile Dysfunction Medicine Sales by Country (2017-2028)
6.3.2 North America Erectile Dysfunction Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Erectile Dysfunction Medicine Market Size by Type
7.1.1 Europe Erectile Dysfunction Medicine Sales by Type (2017-2028)
7.1.2 Europe Erectile Dysfunction Medicine Revenue by Type (2017-2028)
7.2 Europe Erectile Dysfunction Medicine Market Size by Distribution Channel
7.2.1 Europe Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2028)
7.2.2 Europe Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2028)
7.3 Europe Erectile Dysfunction Medicine Market Size by Country
7.3.1 Europe Erectile Dysfunction Medicine Sales by Country (2017-2028)
7.3.2 Europe Erectile Dysfunction Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Erectile Dysfunction Medicine Market Size by Type
8.1.1 Asia Pacific Erectile Dysfunction Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Erectile Dysfunction Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Erectile Dysfunction Medicine Market Size by Distribution Channel
8.2.1 Asia Pacific Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific Erectile Dysfunction Medicine Market Size by Region
8.3.1 Asia Pacific Erectile Dysfunction Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Erectile Dysfunction Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Erectile Dysfunction Medicine Market Size by Type
9.1.1 Latin America Erectile Dysfunction Medicine Sales by Type (2017-2028)
9.1.2 Latin America Erectile Dysfunction Medicine Revenue by Type (2017-2028)
9.2 Latin America Erectile Dysfunction Medicine Market Size by Distribution Channel
9.2.1 Latin America Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2028)
9.2.2 Latin America Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2028)
9.3 Latin America Erectile Dysfunction Medicine Market Size by Country
9.3.1 Latin America Erectile Dysfunction Medicine Sales by Country (2017-2028)
9.3.2 Latin America Erectile Dysfunction Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Erectile Dysfunction Medicine Market Size by Type
10.1.1 Middle East and Africa Erectile Dysfunction Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Erectile Dysfunction Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Erectile Dysfunction Medicine Market Size by Distribution Channel
10.2.1 Middle East and Africa Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa Erectile Dysfunction Medicine Market Size by Country
10.3.1 Middle East and Africa Erectile Dysfunction Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Erectile Dysfunction Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Overview
11.1.3 Pfizer, Inc. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer, Inc. Recent Developments
11.2 Dong-A ST Co., Ltd.
11.2.1 Dong-A ST Co., Ltd. Corporation Information
11.2.2 Dong-A ST Co., Ltd. Overview
11.2.3 Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dong-A ST Co., Ltd. Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Overview
11.3.3 Eli Lilly and Company Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly and Company Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly and Company Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Corporation Information
11.4.2 Bayer AG Overview
11.4.3 Bayer AG Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bayer AG Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer AG Recent Developments
11.5 Vivus, Inc.
11.5.1 Vivus, Inc. Corporation Information
11.5.2 Vivus, Inc. Overview
11.5.3 Vivus, Inc. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Vivus, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vivus, Inc. Recent Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd. Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.7 SK Chemicals
11.7.1 SK Chemicals Corporation Information
11.7.2 SK Chemicals Overview
11.7.3 SK Chemicals Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 SK Chemicals Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SK Chemicals Recent Developments
11.8 Meda Pharmaceuticals, Inc.
11.8.1 Meda Pharmaceuticals, Inc. Corporation Information
11.8.2 Meda Pharmaceuticals, Inc. Overview
11.8.3 Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Meda Pharmaceuticals, Inc. Recent Developments
11.9 Cristalia Produtos Quimicos Farmaceuticos Ltda
11.9.1 Cristalia Produtos Quimicos Farmaceuticos Ltda Corporation Information
11.9.2 Cristalia Produtos Quimicos Farmaceuticos Ltda Overview
11.9.3 Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cristalia Produtos Quimicos Farmaceuticos Ltda Recent Developments
11.10 Apricus Biosciences, Inc.
11.10.1 Apricus Biosciences, Inc. Corporation Information
11.10.2 Apricus Biosciences, Inc. Overview
11.10.3 Apricus Biosciences, Inc. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Apricus Biosciences, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apricus Biosciences, Inc. Recent Developments
11.11 Futura Medical plc.
11.11.1 Futura Medical plc. Corporation Information
11.11.2 Futura Medical plc. Overview
11.11.3 Futura Medical plc. Erectile Dysfunction Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Futura Medical plc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Futura Medical plc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Erectile Dysfunction Medicine Industry Chain Analysis
12.2 Erectile Dysfunction Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Erectile Dysfunction Medicine Production Mode & Process
12.4 Erectile Dysfunction Medicine Sales and Marketing
12.4.1 Erectile Dysfunction Medicine Sales Channels
12.4.2 Erectile Dysfunction Medicine Distributors
12.5 Erectile Dysfunction Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Erectile Dysfunction Medicine Industry Trends
13.2 Erectile Dysfunction Medicine Market Drivers
13.3 Erectile Dysfunction Medicine Market Challenges
13.4 Erectile Dysfunction Medicine Market Restraints
14 Key Findings in The Global Erectile Dysfunction Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Erectile Dysfunction Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Viagra
Table 3. Major Manufacturers of Cialis
Table 4. Major Manufacturers of Levitra
Table 5. Major Manufacturers of Stendra
Table 6. Global Erectile Dysfunction Medicine Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Erectile Dysfunction Medicine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Erectile Dysfunction Medicine Sales by Region (2017-2022) & (K Units)
Table 9. Global Erectile Dysfunction Medicine Sales Market Share by Region (2017-2022)
Table 10. Global Erectile Dysfunction Medicine Sales by Region (2023-2028) & (K Units)
Table 11. Global Erectile Dysfunction Medicine Sales Market Share by Region (2023-2028)
Table 12. Global Erectile Dysfunction Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Erectile Dysfunction Medicine Revenue Market Share by Region (2017-2022)
Table 14. Global Erectile Dysfunction Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Erectile Dysfunction Medicine Revenue Market Share by Region (2023-2028)
Table 16. Global Erectile Dysfunction Medicine Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Erectile Dysfunction Medicine Sales Share by Manufacturers (2017-2022)
Table 18. Global Erectile Dysfunction Medicine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Erectile Dysfunction Medicine Revenue Share by Manufacturers (2017-2022)
Table 20. Erectile Dysfunction Medicine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Erectile Dysfunction Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Erectile Dysfunction Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Medicine as of 2021)
Table 23. Erectile Dysfunction Medicine Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Erectile Dysfunction Medicine Product Offered
Table 25. Date of Manufacturers Enter into Erectile Dysfunction Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 28. Global Erectile Dysfunction Medicine Sales by Type (2023-2028) & (K Units)
Table 29. Global Erectile Dysfunction Medicine Sales Share by Type (2017-2022)
Table 30. Global Erectile Dysfunction Medicine Sales Share by Type (2023-2028)
Table 31. Global Erectile Dysfunction Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Erectile Dysfunction Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Erectile Dysfunction Medicine Revenue Share by Type (2017-2022)
Table 34. Global Erectile Dysfunction Medicine Revenue Share by Type (2023-2028)
Table 35. Erectile Dysfunction Medicine Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Erectile Dysfunction Medicine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 38. Global Erectile Dysfunction Medicine Sales by Distribution Channel (2023-2028) & (K Units)
Table 39. Global Erectile Dysfunction Medicine Sales Share by Distribution Channel (2017-2022)
Table 40. Global Erectile Dysfunction Medicine Sales Share by Distribution Channel (2023-2028)
Table 41. Global Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 42. Global Erectile Dysfunction Medicine Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 43. Global Erectile Dysfunction Medicine Revenue Share by Distribution Channel (2017-2022)
Table 44. Global Erectile Dysfunction Medicine Revenue Share by Distribution Channel (2023-2028)
Table 45. Erectile Dysfunction Medicine Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 46. Global Erectile Dysfunction Medicine Price Forecast by Distribution Channel (2023-2028) & (US$/Unit)
Table 47. North America Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 48. North America Erectile Dysfunction Medicine Sales by Type (2023-2028) & (K Units)
Table 49. North America Erectile Dysfunction Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Erectile Dysfunction Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 52. North America Erectile Dysfunction Medicine Sales by Distribution Channel (2023-2028) & (K Units)
Table 53. North America Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 54. North America Erectile Dysfunction Medicine Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 55. North America Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 56. North America Erectile Dysfunction Medicine Sales by Country (2023-2028) & (K Units)
Table 57. North America Erectile Dysfunction Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Erectile Dysfunction Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 60. Europe Erectile Dysfunction Medicine Sales by Type (2023-2028) & (K Units)
Table 61. Europe Erectile Dysfunction Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Erectile Dysfunction Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 64. Europe Erectile Dysfunction Medicine Sales by Distribution Channel (2023-2028) & (K Units)
Table 65. Europe Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 66. Europe Erectile Dysfunction Medicine Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 67. Europe Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 68. Europe Erectile Dysfunction Medicine Sales by Country (2023-2028) & (K Units)
Table 69. Europe Erectile Dysfunction Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Erectile Dysfunction Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Erectile Dysfunction Medicine Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Erectile Dysfunction Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Erectile Dysfunction Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 76. Asia Pacific Erectile Dysfunction Medicine Sales by Distribution Channel (2023-2028) & (K Units)
Table 77. Asia Pacific Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 78. Asia Pacific Erectile Dysfunction Medicine Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 79. Asia Pacific Erectile Dysfunction Medicine Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Erectile Dysfunction Medicine Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Erectile Dysfunction Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Erectile Dysfunction Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Erectile Dysfunction Medicine Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Erectile Dysfunction Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Erectile Dysfunction Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 88. Latin America Erectile Dysfunction Medicine Sales by Distribution Channel (2023-2028) & (K Units)
Table 89. Latin America Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 90. Latin America Erectile Dysfunction Medicine Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 91. Latin America Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Erectile Dysfunction Medicine Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Erectile Dysfunction Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Erectile Dysfunction Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Erectile Dysfunction Medicine Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Erectile Dysfunction Medicine Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Erectile Dysfunction Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Erectile Dysfunction Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Erectile Dysfunction Medicine Sales by Distribution Channel (2017-2022) & (K Units)
Table 100. Middle East and Africa Erectile Dysfunction Medicine Sales by Distribution Channel (2023-2028) & (K Units)
Table 101. Middle East and Africa Erectile Dysfunction Medicine Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Erectile Dysfunction Medicine Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Erectile Dysfunction Medicine Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Erectile Dysfunction Medicine Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Erectile Dysfunction Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Erectile Dysfunction Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 107. Pfizer, Inc. Corporation Information
Table 108. Pfizer, Inc. Description and Major Businesses
Table 109. Pfizer, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Pfizer, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer, Inc. Recent Developments
Table 112. Dong-A ST Co., Ltd. Corporation Information
Table 113. Dong-A ST Co., Ltd. Description and Major Businesses
Table 114. Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Dong-A ST Co., Ltd. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Dong-A ST Co., Ltd. Recent Developments
Table 117. Eli Lilly and Company Corporation Information
Table 118. Eli Lilly and Company Description and Major Businesses
Table 119. Eli Lilly and Company Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Eli Lilly and Company Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Eli Lilly and Company Recent Developments
Table 122. Bayer AG Corporation Information
Table 123. Bayer AG Description and Major Businesses
Table 124. Bayer AG Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Bayer AG Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bayer AG Recent Developments
Table 127. Vivus, Inc. Corporation Information
Table 128. Vivus, Inc. Description and Major Businesses
Table 129. Vivus, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Vivus, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Vivus, Inc. Recent Developments
Table 132. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 133. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 134. Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Teva Pharmaceutical Industries Ltd. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 137. SK Chemicals Corporation Information
Table 138. SK Chemicals Description and Major Businesses
Table 139. SK Chemicals Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. SK Chemicals Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. SK Chemicals Recent Developments
Table 142. Meda Pharmaceuticals, Inc. Corporation Information
Table 143. Meda Pharmaceuticals, Inc. Description and Major Businesses
Table 144. Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Meda Pharmaceuticals, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Meda Pharmaceuticals, Inc. Recent Developments
Table 147. Cristalia Produtos Quimicos Farmaceuticos Ltda Corporation Information
Table 148. Cristalia Produtos Quimicos Farmaceuticos Ltda Description and Major Businesses
Table 149. Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Cristalia Produtos Quimicos Farmaceuticos Ltda Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Cristalia Produtos Quimicos Farmaceuticos Ltda Recent Developments
Table 152. Apricus Biosciences, Inc. Corporation Information
Table 153. Apricus Biosciences, Inc. Description and Major Businesses
Table 154. Apricus Biosciences, Inc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Apricus Biosciences, Inc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Apricus Biosciences, Inc. Recent Developments
Table 157. Futura Medical plc. Corporation Information
Table 158. Futura Medical plc. Description and Major Businesses
Table 159. Futura Medical plc. Erectile Dysfunction Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Futura Medical plc. Erectile Dysfunction Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Futura Medical plc. Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Erectile Dysfunction Medicine Distributors List
Table 165. Erectile Dysfunction Medicine Customers List
Table 166. Erectile Dysfunction Medicine Market Trends
Table 167. Erectile Dysfunction Medicine Market Drivers
Table 168. Erectile Dysfunction Medicine Market Challenges
Table 169. Erectile Dysfunction Medicine Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Erectile Dysfunction Medicine Product Picture
Figure 3. Global Erectile Dysfunction Medicine Market Share by Type in 2021 & 2028
Figure 3. Viagra Product Picture
Figure 4. Cialis Product Picture
Figure 5. Levitra Product Picture
Figure 6. Stendra Product Picture
Figure 7. Global Erectile Dysfunction Medicine Market Share by Distribution Channel in 2021 & 2028
Figure 8. Online Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Hospital
Figure 11. Erectile Dysfunction Medicine Report Years Considered
Figure 12. Global Erectile Dysfunction Medicine Sales 2017-2028 (K Units)
Figure 13. Global Erectile Dysfunction Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Erectile Dysfunction Medicine Revenue 2017-2028 (US$ Million)
Figure 15. Global Erectile Dysfunction Medicine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Erectile Dysfunction Medicine Sales Market Share by Region (2017-2022)
Figure 17. Global Erectile Dysfunction Medicine Sales Market Share by Region (2023-2028)
Figure 18. North America Erectile Dysfunction Medicine Sales YoY (2017-2028) & (K Units)
Figure 19. North America Erectile Dysfunction Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Erectile Dysfunction Medicine Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Erectile Dysfunction Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Erectile Dysfunction Medicine Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Erectile Dysfunction Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Erectile Dysfunction Medicine Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Erectile Dysfunction Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Erectile Dysfunction Medicine Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Erectile Dysfunction Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Erectile Dysfunction Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Erectile Dysfunction Medicine in the World: Market Share by Erectile Dysfunction Medicine Revenue in 2021
Figure 30. Global Erectile Dysfunction Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
Figure 32. Global Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
Figure 33. Global Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
Figure 34. Global Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
Figure 35. North America Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
Figure 36. North America Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
Figure 37. North America Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
Figure 38. North America Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
Figure 39. North America Erectile Dysfunction Medicine Sales Share by Country (2017-2028)
Figure 40. North America Erectile Dysfunction Medicine Revenue Share by Country (2017-2028)
Figure 41. United States Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
Figure 44. Europe Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
Figure 45. Europe Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
Figure 46. Europe Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
Figure 47. Europe Erectile Dysfunction Medicine Sales Share by Country (2017-2028)
Figure 48. Europe Erectile Dysfunction Medicine Revenue Share by Country (2017-2028)
Figure 49. Germany Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 50. France Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
Figure 57. Asia Pacific Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
Figure 58. Asia Pacific Erectile Dysfunction Medicine Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Erectile Dysfunction Medicine Revenue Share by Region (2017-2028)
Figure 60. China Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 63. India Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
Figure 70. Latin America Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
Figure 72. Latin America Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
Figure 73. Latin America Erectile Dysfunction Medicine Sales Share by Country (2017-2028)
Figure 74. Latin America Erectile Dysfunction Medicine Revenue Share by Country (2017-2028)
Figure 75. Mexico Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Erectile Dysfunction Medicine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Erectile Dysfunction Medicine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Erectile Dysfunction Medicine Sales Market Share by Distribution Channel (2017-2028)
Figure 81. Middle East and Africa Erectile Dysfunction Medicine Revenue Market Share by Distribution Channel (2017-2028)
Figure 82. Middle East and Africa Erectile Dysfunction Medicine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Erectile Dysfunction Medicine Revenue Share by Country (2017-2028)
Figure 84. Turkey Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Erectile Dysfunction Medicine Revenue (2017-2028) & (US$ Million)
Figure 87. Erectile Dysfunction Medicine Value Chain
Figure 88. Erectile Dysfunction Medicine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---